DarioHealth, GreenKey seek to ‘reshape’ sleep apnea 

NEW YORK and SAN FRANCISCO – A new strategic commercial agreement unites DarioHealth’s clinically validated cardiometabolic and behavioral artificial intelligence-powered health solutions with GreenKey’s “sleep-first” approach to obstructive sleep apnea management. The companies say they aim to drive awareness and secure payer contracts through a robust multi-channel marketing plan designed to engage Commercial, ASO ('Administrative Services Only), Medicaid and Medicare Advantage plans, as well as self-funded employers, consultants, brokers and value-based care providers. "We believe that this agreement marks a pivotal step forward in reshaping how chronic conditions like sleep apnea and cardiometabolic disorders are addressed in tandem," said Steven Nelson, chief commercial officer at Dario. "By combining our real-time engagement and data-driven platform with GreenKey's powerful OSA cost-saving engine, we are offering payers a differentiated, value-based care solution that not only improves health outcomes but significantly reduces the total cost of care. This collaboration opens access to a multi-billion-dollar market and aligns perfectly with our mission to provide integrated, data-driven solutions for the most prevalent and costly chronic conditions facing healthcare today." The companies say they will use a mix of targeted outreach, thought leadership and high-impact content to connect with decision-makers and advance adoption of this innovative, value-based care model. They say benefits of the model include: 

• Improved member outcomes through enhanced sleep health, optimized GLP-1 utilization and effective comorbidity management 
• Reduced health care costs with decreased emergency department and inpatient utilization 
• Increased productivity from better sleep and overall health 
• Actionable data Insights to continuously optimize program performance